Search for: "BROWN v. CITY OF PHILADELPHIA OFFICE OF HUMAN RESOURCES" Results 1 - 18 of 18
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jan 2011, 1:04 pm by axd10
Philadelphia, PA Executive Office, American Law Institute, 2009. [read post]
16 Jun 2020, 5:14 am by Richard Altieri, Margaret Taylor
” Indeed, prior to Little Rock, Eisenhower had been reluctant to lend federal muscle to desegregation efforts in the South in the years following the Supreme Court’s decision in Brown v. [read post]
25 Feb 2010, 10:57 am by admin
EPA Region 10 offices, located at 1200  Sixth Avenue, Seattle, Washington 98101. [read post]
9 Aug 2019, 3:00 am by Jim Sedor
Philadelphia Inquirer – Michael Brice-Saddler (Washington Post) | Published: 8/6/2019 The 44 names that U.S. [read post]
19 Jan 2015, 6:28 pm
It had its legal beginning in 1896, when the Supreme Court rendered a decision known as the Plessy v. [read post]
29 Dec 2022, 9:05 pm by Victoria Hawekotte
  JUNE The Supreme Court, in a 6-3 decision, overturned Roe v. [read post]
11 Feb 2011, 7:51 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
30 May 2012, 1:37 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
22 Jun 2011, 7:09 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
2 Oct 2010, 8:43 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
15 Feb 2012, 7:42 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
9 Sep 2011, 8:40 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]